In vitro cytotoxicity of SiO2 or ZnO nanoparticles with different sizes and surface charges on U373MG human glioblastoma cells

International Journal of Nanomedicine

Volumn 9, Issue , 2014, Pages 235-241

  Kim, Jung Eun ^a   Kim, Hyejin ^a   An, Seong Soo A ^b   Maeng, Eun Ho ^c   Kim, Meyoung Kon ^d   Song, Yoon Jae ^a  

^a Department of Life Science ^*  (South Korea)

^b Gachon University   (South Korea)

^c Korea Testing and Research Institute   (South Korea)

^d Korea University   (South Korea)

Author keywords

Apoptosis

Indexed keywords

CASPASE 3; DNA; SILICA NANOPARTICLE; ZINC OXIDE NANOPARTICLE; METAL NANOPARTICLE; SILICON DIOXIDE; ZINC OXIDE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL; NEUROTOXICITY; PARTICLE SIZE; SURFACE CHARGE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GLIOBLASTOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; GLIOBLASTOMA; HUMANS; METAL NANOPARTICLES; SILICON DIOXIDE; ZINC OXIDE;

EID: 84939211881     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S57936     Document Type: Article

References (39)

1. Ma H, Williams PL, Diamond SA. Ecotoxicity of manufactured ZnO nanoparticles – a review. Environ Pollut. 2013;172:76–85.
2. Uskokovic´ V. Entering the era of nanoscience: time to be so small. J Biomed Nanotechnol. 2013;9(9):1441–1470.
3. Fan Z, Lu JG. Zinc oxide nanostructures: synthesis and properties. J Nanosci Nanotechnol. 2005;5(10):1561–1573.
4. Fine D, Grattoni A, Goodall R, et al. Silicon micro- and nanofabrication for medicine. Adv Healthc Mater. 2013;2(5):632–666.
5. Nasir A. Nanotechnology and dermatology: part II – risks of nanotechnology. Clin Dermatol. 2010;28(5):581–588.
6. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology. 2009;20(45):455101.
7. Lundqvist M, Stigler J, Cedervall T, et al. The evolution of the pro­tein corona around nanoparticles: a test study. ACS Nano. 2011;5(9):7503–7509.
8. Okoturo-Evans O, Dybowska A, Valsami-Jones E, et al. Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles. PLoS One. 2013;8(9):e72363.
9. Ekkapongpisit M, Giovia A, Follo C, Caputo G, Isidoro C. Biocompatibility, endocytosis, and intracellular trafficking of mes­oporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups. Int J Nanomedicine. 2012;7: 4147–4158.
10. Lee SH, Pie JE, Kim YR, Lee HR, Son SW, Kim MK. Effects of zinc oxide nanoparticles on gene expression profile in human keratinocytes. Mol Cell Toxicol. 2012;8(2):113–118.
11. Bauer AT, Strozyk EA, Gorzelanny C, et al. Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials. 2011;32(33):8385–8393.
12. Rabolli V, Thomassen LC, Princen C, et al. Influence of size, surface area and microporosity on the in vitro cytotoxic activity of amorphous silica nanoparticles in different cell types. Nanotoxicology. 2010;4(3): 307–318.
13. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbal­ance in human endothelial cells: inflammatory and cytotoxic effects. Int J Nanomedicine. 2011;6:2821–2835.
14. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2(10): 2121–2134.
15. Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxidative stress and genotoxicity in human liver cells (HepG2). J Biomed Nanotechnol. 2011;7(1):98–99.
16. Sharma V, Singh P, Pandey AK, Dhawan A. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat Res. 2012;745(1–2):84–91.
17. Sharma V, Anderson D, Dhawan A. Zinc oxide nanoparticles induce oxi­dative DNA damage and ROS-triggered mitochondria mediated apop­tosis in human liver cells (HepG2). Apoptosis. 2012;17(8):852–870.
18. Cho WS, Duffin R, Poland CA, et al. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ Health Perspect. 2010;118(12): 1699–1706.
19. Kermanizadeh A, Pojana G, Gaiser BK, et al. In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers. Nanotoxicology. 2013;7(3):301–313.
20. Xu Z, Chou L, Sun J. Effects of SiO2 nanoparticles on HFL-I acti­vating ROS-mediated apoptosis via p53 pathway. J Appl Toxicol. 2012;32(5):358–364.
21. Ahamed M. Silica nanoparticles-induced cytotoxicity, oxidative stress and apoptosis in cultured A431 and A549 cells. Hum Exp Toxicol. 2013;32(2):186–195.
22. Ahamed M, Akhtar MJ, Raja M, et al. ZnO nanorod-induced apoptosis in human alveolar adenocarcinoma cells via p53, survivin and bax/bcl-2 pathways: role of oxidative stress. Nanomedicine. 2011;7(6): 904–913.
23. Meyer K, Rajanahalli P, Ahamed M, Rowe JJ, Hong Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol In Vitro. 2011;25(8):1721–1726.
24. Wilhelmi V, Fischer U, Weighardt H, et al. Zinc oxide nanoparticles induce necrosis and apoptosis in macrophages in a p47phox- and Nrf2-independent manner. PLoS One. 2013;8(6):e65704.
25. Kim K-M, Kim T-H, Kim H-M, et al. Colloidal behaviors of ZnO nanoparticles in various aqueous media. Toxicol Environ Health Sci. 2012;4(2):121–131.
26. Kim KM, Choi MH, Lee JK, et al. Physicochemical properties of sur­face charge-modified ZnO nanomaterials with different particle sizes. In press 2014.
27. Song YJ, Stinski MF. Inhibition of cell division by the human cyto­megalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1. J Virol. 2005;79(4):2597–2603.
28. Park YH, Bae HC, Jang Y, et al. Effect of the size and surface charge of silica nanoparticles on cutaneous toxicity. Mol Cell Toxicol. 2013;9(1): 67–74.
29. Greish K, Thiagarajan G, Herd H, et al. Size and surface charge sig­nificantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology. 2012;6(7):713–723.
30. Pujalté I, Passagne I, Brouillaud B, et al. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part Fibre Toxicol. 2011;8:10.
31. Malvindi MA, Brunetti V, Vecchio G, Galeone A, Cingolani R, Pompa PP. SiO2 nanoparticles biocompatibility and their potential for gene delivery and silencing. Nanoscale. 2012;4(2):486–495.
32. Bae HC, Ryu HJ, Jeong SH, et al. Oxidative stress and apoptosis induced by ZnO nanoparticles in HaCaT cells. Mol Cell Toxicol. 2011;7(4):333–337.
33. Hsiao IL, Huang YJ. Effects of various physicochemical characteristics on the toxicities of ZnO and TiO nanoparticles toward human lung epithelial cells. Sci Total Environ. 2011;409(7):1219–1228.
34. Speidel D. Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol. 2010;20(1):14–24.
35. McNamee LM, Brodsky MH. p53-independent apoptosis limits DNA damage-induced aneuploidy. Genetics. 2009;182(2):423–435.
36. Cuddihy AR, O’Connell MJ. Cell-cycle responses to DNA damage in G2. Int Rev Cytol. 2003;222:99–140.
37. Duan J, Yu Y, Li Y, Zhou X, Huang P, Sun Z. Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint. PLoS One. 2013;8(4):e62087.
38. Ou YH, Chung PH, Sun TP, Shieh SY. p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell. 2005;16(4):1684–1695.
39. Chung JH, Bunz F. Cdk2 is required for p53-independent G2/M checkpoint control. PLoS Genet. 2010;6(2):e1000863.